Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar;25(3):69-74.
doi: 10.1007/s11894-023-00862-z. Epub 2023 Mar 2.

Ethical Implications of Nutrition Therapy at the End of Life

Affiliations
Review

Ethical Implications of Nutrition Therapy at the End of Life

Katie L Bower et al. Curr Gastroenterol Rep. 2023 Mar.

Abstract

Purpose of review: Provide an evidence-based resource to inform ethically sound recommendations regarding end of life nutrition therapy.

Recent findings: • Some patients with a reasonable performance status can temporarily benefit from medically administered nutrition and hydration(MANH) at the end of life. • MANH is contraindicated in advanced dementia. • MANH eventually becomes nonbeneficial or harmful in terms of survival, function, and comfort for all patients at end of life. • Shared decision-making is a practice based on relational autonomy, and the ethical gold standard in end of life decisions. A treatment should be offered if there is expectation of benefit, but clinicians are not obligated to offer non-beneficial treatments. A decision to proceed or not should be based on the patient's values and preferences, a discussion of all potential outcomes, prognosis for given outcomes taking into consideration disease trajectory and functional status, and physician guidance provided in the form of a recommendation.

Keywords: Artificial nutrition; End of life; Enteral nutrition; Ethics; Medically administered nutrition; Parenteral nutrition; Shared decision-making.

PubMed Disclaimer

References

    1. Konsman JP, Parnet P, Dantzer R. Cytokine. Trends Neurosci. 2002;25(3):154–9. https://doi.org/10.1016/s0166-2236(00)02088-9 . - DOI - PubMed
    1. Francesconi W, Sánchez-Alavez M, Berton F, Alboni S, Benatti C, Mori S, et al. The Proinflammatory Cytokine Interleukin 18 Regulates Feeding by Acting on the Bed Nucleus of the Stria Terminalis. J Neurosci. 2016;36(18):5170–80. https://doi.org/10.1523/jneurosci.3919-15.2016 . - DOI - PubMed - PMC
    1. Alboni S, Cervia D, Ross B, Montanari C, Gonzalez AS, Sanchez-Alavez M, et al. Mapping of the full length and the truncated interleukin-18 receptor alpha in the mouse brain. J Neuroimmunol. 2009;214(1–2):43–54. https://doi.org/10.1016/j.jneuroim.2009.06.016 . - DOI - PubMed - PMC
    1. Alboni S, Cervia D, Sugama S, Conti B. Interleukin 18 in the CNS. J Neuroinflammation. 2010;7(1):9. https://doi.org/10.1186/1742-2094-7-9 . - DOI - PubMed - PMC
    1. Alboni S, Montanari C, Benatti C, Blom JMC, Simone ML, Brunello N, et al. Constitutive and LPS-regulated expression of interleukin-18 receptor beta variants in the mouse brain. Brain Behav Immun. 2011;25(3):483–93. https://doi.org/10.1016/j.bbi.2010.11.011 . - DOI - PubMed

LinkOut - more resources